Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

  1. Home
  2. NLST
  3. Publications

NLST Publications

Here you can browse the complete list of publications for NLST

Studies
Publication Year
Reset

Results: 140 (Showing 61 to 80) — Export these results

Title PubMed Id Authors Journal Abbreviation Year Studies
A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. 25863905 Wilson DO, Weissfeld J Lung Cancer 2015 NLST
The Relations between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Cancer Screening Trial: Implications for Public Health. 25746779 Clark MA, Gorelick JJ, Sicks JD, Park ER, Graham AL, Abrams DB, Gareen IF Nicotine Tob. Res. 2015 NLST
Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment. 25664444 Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E Ann. Intern. Med. 2015 NLST
A Query Tool for Investigator Access to the Data and Images of the National Lung Screening Trial. 25739345 Commean PK, Rathmell JM, Clark KW, Maffitt DR, Prior FW J Digit Imaging 2015 NLST
Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. 25759972 Chiles C, Duan F, Gladish GW, Ravenel JG, Baginski SG, Snyder BS, DeMello S, Desjardins SS, Munden RF, For of the NLST Study Team Radiology 2015 NLST
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. 26238115 Gohagan JK, Prorok PC, Greenwald P, Kramer BS Rev Recent Clin Trials 2015 NLST, PLCO
Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. 26712960 Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER Oncologist 2015 NLST
National Lung Screening Trial Findings by Age: Medicare-Eligible Versus Under-65 Population. 25199624 Pinsky PF, Gierada DS, Hocking W, Patz EF, Kramer BS Ann. Intern. Med. 2014 NLST
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. 25065710 Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C Cancer 2014 NLST
CT Screening for Lung Cancer: Alternative Definitions of Positive Test Result Based on the National Lung Screening Trial and International Early Lung Cancer Action Program Databases. 24955929 Yip R, Henschke CI, Yankelevitz DF, Smith JP Radiology 2014 NLST
Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. 25326638 Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR J. Natl. Cancer Inst. 2014 NLST
Cost-effectiveness of CT screening in the National Lung Screening Trial. 25372087 Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C, National Lung Screening Trial Research Team N. Engl. J. Med. 2014 NLST
A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants. 23999653 Park ER, Streck JM, Gareen IF, Ostroff JS, Hyland KA, Rigotti NA, Pajolek H, Nichter M Nicotine Tob. Res. 2014 NLST
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. 25044253 Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y Urol. Oncol. 2014 NLST, PLCO
Short- and Long-term Lung Cancer Risk Associated with Noncalcified Nodules Observed on Low-Dose CT. 24755313 Pinsky PF, Nath PH, Gierada DS, Sonavane S, Szabo E Cancer Prev Res (Phila) 2014 NLST
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. 24577803 Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK Cancer 2014 NLST, PLCO
The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. 25089376 Yip R, Henschke CI, Yankelevitz DF, Boffetta P, Smith JP, The International Early Lung Cancer Investigators Eur. J. Cancer Prev. 2014 NLST
Overdiagnosis in low-dose computed tomography screening for lung cancer. 24322569 Patz EF, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR, NLST Overdiagnosis Manuscript Writing Team JAMA Intern Med 2014 NLST
Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts. 25460915 Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD PLoS Med. 2014 NLST, PLCO
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. 24379002 de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammemägi MC, Hazelton WD, Feuer EJ, McMahon PM Ann. Intern. Med. 2014 NLST